Literature DB >> 20208003

Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.

Kathleen A Stuller1, Stephanie S Cush, Emilio Flaño.   

Abstract

The direct effector mechanisms of CD4 T cells during gamma-herpesvirus 68 (gammaHV68)-persistent infection are less well understood than those of their CD8 T cell counterparts, although there is substantial evidence that CD4 T cells are critical for the control of persistent gamma-herpesvirus infection. Our results show that in gammaHV68-persistently infected mice, CD4 T cells are not cytokine polyfunctional, but there is a division of labor in the CD4 T cell compartment in which CD4 T cells polarize toward two distinct populations with different effector functions: IFN-gamma producers and CD107(+) cytolytic effectors. These two CD4 T cell effector populations degranulate and produce IFN-gamma during steady state without need for exogenous antigenic restimulation, which is fundamentally different from that observed with gammaHV68-specific CD8 T cells. By using anti-IFN-gamma Ab depletions and IFN-gamma-deficient mice, we show that CD4 T cell-mediated cytotoxicity in vivo is not dependent on IFN-gamma activity. In addition, our data show that purified CD4 T cells isolated from gammaHV68-latently infected mice have the capacity to inhibit gammaHV68 reactivation from latency. Our results support the concept that CD4 T cells are critical effectors for the control of gamma-herpesvirus latent infection, and they mediate this effect by two independent mechanisms: IFN-gamma production and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208003      PMCID: PMC3044337          DOI: 10.4049/jimmunol.0902935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  S Nikiforow; K Bottomly; G Miller
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.

Authors:  Kevin N Heller; Jenica Upshaw; Beza Seyoum; Henry Zebroski; Christian Münz
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

3.  Memory generation and maintenance of CD8+ T cell function during viral persistence.

Authors:  Stephanie S Cush; Kathleen M Anderson; David H Ravneberg; Janet L Weslow-Schmidt; Emilio Flaño
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

4.  CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection.

Authors:  Kathleen A Stuller; Emilio Flaño
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

5.  The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection.

Authors:  Senta M Walton; Philippe Wyrsch; Michael W Munks; Albert Zimmermann; Hartmut Hengel; Ann B Hill; Annette Oxenius
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

6.  Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes.

Authors:  K A Robertson; E J Usherwood; A A Nash
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 7.  Functional signatures of protective antiviral T-cell immunity in human virus infections.

Authors:  Alexandre Harari; Valérie Dutoit; Cristina Cellerai; Pierre-Alexandre Bart; Renaud A Du Pasquier; Giuseppe Pantaleo
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

Review 8.  Th1 memory: implications for vaccine development.

Authors:  Kathryn E Foulds; Chang-you Wu; Robert A Seder
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

9.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Authors:  K Bickham; C Münz; M L Tsang; M Larsson; J F Fonteneau; N Bhardwaj; R Steinman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

10.  Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

Authors:  C Münz; K L Bickham; M Subklewe; M L Tsang; A Chahroudi; M G Kurilla; D Zhang; M O'Donnell; R M Steinman
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  17 in total

1.  Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Authors:  Zhuting Hu; Marcia A Blackman; Kenneth M Kaye; Edward J Usherwood
Journal:  J Immunol       Date:  2015-02-06       Impact factor: 5.422

2.  CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.

Authors:  Zulkarnain Harfuddin; Shaqireen Kwajah; Adrian Chong Nyi Sim; Paul Anthony Macary; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-11-11       Impact factor: 8.110

3.  CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic.

Authors:  Michael L Freeman; Claire E Burkum; Tres Cookenham; Alan D Roberts; Kathleen G Lanzer; Gail E Huston; Meghan K Jensen; John Sidney; Bjoern Peters; Jacob E Kohlmeier; David L Woodland; Linda F van Dyk; Alessandro Sette; Marcia A Blackman
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

Review 4.  Cytolytic CD4(+) T cells in viral immunity.

Authors:  Damien Z Soghoian; Hendrik Streeck
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

5.  Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection.

Authors:  Deborah M Brown; Sarah Lee; Maria de la Luz Garcia-Hernandez; Susan L Swain
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

Review 6.  Prospects of a novel vaccination strategy for human gamma-herpesviruses.

Authors:  Ting-Ting Wu; Marcia A Blackman; Ren Sun
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

7.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

Review 8.  Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.

Authors:  Jianmin Zuo; Martin Rowe
Journal:  Viruses       Date:  2012-08-22       Impact factor: 5.048

9.  Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.

Authors:  Mark J Dobrzanski
Journal:  Front Oncol       Date:  2013-03-26       Impact factor: 6.244

10.  High efficiency of antiviral CD4(+) killer T cells.

Authors:  Steven K Hildemann; Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Dirk Homann
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.